Research chemicals only · Not for human use · DYOR

Peply Labs
Back to Research Hub
📊
#12 popular
Strong human
Growth Hormone
Metabolic

Tesamorelin

aka TH-9507, Egrifta

FDA-approved GHRH analog—visceral fat reduction & cognition

MW (Da)

5,135.78

Half-life

~26 min

Sequence

Trans-3-hexenoyl-Tyr-Ala-Asp-Ala-...

Storage

Lyophilized 2–8 °C. Reconstituted refrigerate, 14 days per label.

Research chemicals only. Not for human use. For research and educational purposes only. Always do your own due diligence and consult qualified professionals.

Hover any underlined term for a plain-English definition.

Safety at a glance

Full safety details

Most-reported side effects

  • Injection-site redness
  • Joint stiffness

Don't use if…

  • Active malignancy
  • Pituitary tumor / hypopituitarism
  • Pregnancy

What it is

Stabilized GHRH analog (Egrifta), FDA-approved for HIV-associated lipodystrophy. Best human evidence among GHRH peptides for visceral fat reduction and modest cognitive improvements.

Mechanism of action

Binds GHRH receptors and elicits pulsatile GH release. Trans-hexenoyl modification protects from DPP-IV cleavage. Net effect raises IGF-1 within physiological bounds.

Reported benefits

  • Reduces visceral adipose tissue (VAT)
  • Improves serum triglycerides and lean mass
  • Modest cognitive improvements in older adults (NIH trial)

Evidence notes

FDA approval based on multi-center Phase III trials. Best human peptide data of the GHRH class.